Moneycontrol PRO
HomeNewsBusinessStocksJ. K. Cement, GlaxoSmithKline, and Bharti Hexacom Among Top Losers in NIFTY MIDCAP 150

J. K. Cement, GlaxoSmithKline, and Bharti Hexacom Among Top Losers in NIFTY MIDCAP 150

The presented data provides a snapshot of the financial health and recent market performance of key stocks within the NIFTY MIDCAP 150 index.

June 30, 2025 / 11:17 IST
Disclaimer This is an AI-assisted live blog with updates from multiple sources Disclaimer

During today's session, several stocks experienced significant declines, with J. K. Cement, GlaxoSmithKline, and Bharti Hexacom leading the downturn in the NIFTY MIDCAP 150 as of 11.00 am.

J. K. Cement's stock price fell by 3.25%, settling at Rs 6,130.00. Similarly, GlaxoSmithKline's shares dropped by 2.25% to Rs 3,362.10, and Bharti Hexacom saw a decrease of 2.15%, bringing its price to Rs 1,917.90. Other notable losers included SBI Card, which declined by 2.02% to Rs 971.35, and Page Industries, which fell by 1.9% to Rs 48,500.00.

J. K. Cement: Financial Overview


J. K. Cement's financial performance over the past year reveals important insights. The consolidated revenue for March 2025 stood at Rs 3,581.18 Crore, an increase from Rs 2,930.28 Crore in December 2024. The net profit for the same period was Rs 361.39 Crore, compared to Rs 189.22 Crore in the previous quarter. The EPS (Earnings Per Share) also saw an increase, reaching Rs 46.54 in March 2025.

Analyzing the annual data, J. K. Cement has shown consistent growth in revenue and net profit. Revenue increased from Rs 6,606.10 Crore in 2021 to Rs 11,879.15 Crore in 2025. The net profit also rose from Rs 703.10 Crore to Rs 871.58 Crore over the same period. Key financial ratios indicate a healthy financial position, with a Book Value Per Share (BVPS) of Rs 788.01 and a Return on Equity (ROE) of 14.14% in March 2025.

FinancialsMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue (Cr)6,606.107,990.829,720.2011,556.0011,879.15
Net Profit (Cr)703.10679.42419.08789.93871.58
EPS90.9987.9055.17102.35111.44
BVPS480.28555.29600.81688.71788.01
ROE18.9915.889.0914.7314.14
Debt to Equity0.840.891.070.980.97

GlaxoSmithKline: Financial Overview


GlaxoSmithKline's consolidated financials show a similar pattern of growth. The revenue for March 2025 was Rs 974.37 Crore, up from Rs 949.42 Crore in December 2024. The net profit for the same period was Rs 262.87 Crore, compared to Rs 229.88 Crore in the previous quarter. The EPS also increased, reaching Rs 15.52 in March 2025.

Looking at the annual data, GlaxoSmithKline has demonstrated consistent growth in revenue and net profit. Revenue increased from Rs 2,925.60 Crore in 2021 to Rs 3,749.21 Crore in 2025. The net profit also rose significantly from Rs 287.27 Crore to Rs 927.58 Crore over the same period. Key financial ratios include a Book Value Per Share (BVPS) of Rs 115.19 and a Return on Equity (ROE) of 47.67% in March 2025.

FinancialsMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue (Cr)2,925.603,278.033,251.723,453.713,749.21
Net Profit (Cr)287.27380.77607.64589.96927.58
EPS31.3599.2936.0841.1454.52
BVPS87.26157.19102.79104.93115.19
ROE24.2263.6435.4133.4247.67
Debt to Equity0.000.000.000.000.00

Bharti Hexacom: Financial Overview


Bharti Hexacom's standalone financials also reflect growth. For March 2025, the revenue was Rs 4,673 Crore, compared to Rs 4,618 Crore in December 2024. The net profit was Rs 534 Crore, while in the previous quarter it was Rs 383 Crore. The EPS stood at Rs 20.15 for March 2025.

Annually, Bharti Hexacom has increased its revenue from Rs 2,832 Crore in 2021 to Rs 4,934 Crore in 2025. The net profit has risen from Rs 340 Crore to Rs 729 Crore during the same period. Key financial ratios include a Book Value Per Share (BVPS) of Rs 1,261.62 and a Return on Equity (ROE) of 51.81% in March 2025.

FinancialsMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue (Cr)2,8323,8864,7884,5814,934
Net Profit (Cr)340536571569729
EPS305.35481.03512.15510.31653.71
BVPS793.33976.001,229.201,431.711,261.62
ROE38.4849.2841.6635.6451.81
Debt to Equity0.000.000.180.000.00

The presented data provides a snapshot of the financial health and recent market performance of key stocks within the NIFTY MIDCAP 150 index.

Alpha Desk
first published: Jun 30, 2025 11:17 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347